Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nkarta, Inc. | 46,000 | reported | 05 Jun 2025 | tx 6+134,211 |
| Versartis, Inc. | 35,000 | reported | 20 Mar 2014 | tx 1+35,000 |
| SpyGlass Pharma, Inc. | 27,400 | reported | 05 Feb 2026 | tx 1+27,400 |
| Kalaris Therapeutics, Inc. | 18,000 | reported | 10 Apr 2025 | tx 1+18,000 |
| SUTRO BIOPHARMA, INC. | 1,500 | reported | 23 Dec 2025 | tx 9+198,143 |
| Dimension Therapeutics, Inc. | 0 | reported | 07 Nov 2017 | tx 7+2,108,352−3,257,780 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Feb 2026 | GRANT_AWARD | SpyGlass Pharma, Inc. | 27,400 | 0.00 USD | deriv |
| 23 Dec 2025 | GRANT_AWARD | SUTRO BIOPHARMA, INC. | 1,500 | 0.00 USD | deriv |
| 06 Jun 2025 | GRANT_AWARD | SUTRO BIOPHARMA, INC. | 50,000 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Nkarta, Inc. | 46,000 | 0.00 USD | deriv |
| 10 Apr 2025 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 18,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Nkarta, Inc. | 22,500 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | SUTRO BIOPHARMA, INC. | 35,000 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | SUTRO BIOPHARMA, INC. | 25,000 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Nkarta, Inc. | 22,500 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Nkarta, Inc. | 16,000 | 0.00 USD | deriv |
| 06 Jun 2022 | GRANT_AWARD | SUTRO BIOPHARMA, INC. | 18,500 | 0.00 USD | deriv |
| 13 Jun 2021 | GRANT_AWARD | Nkarta, Inc. | 16,511 | 0.00 USD | deriv |
| 03 Jun 2021 | GRANT_AWARD | SUTRO BIOPHARMA, INC. | 18,500 | 0.00 USD | deriv |
| 09 Jul 2020 | GRANT_AWARD | Nkarta, Inc. | 10,700 | 0.00 USD | deriv |
| 05 Jun 2020 | GRANT_AWARD | SUTRO BIOPHARMA, INC. | 12,000 | 0.00 USD | deriv |
| 17 Jun 2019 | GRANT_AWARD | SUTRO BIOPHARMA, INC. | 11,610 | 0.00 USD | deriv |
| 26 Sept 2018 | GRANT_AWARD | SUTRO BIOPHARMA, INC. | 26,033 | 0.00 USD | deriv |
| 07 Nov 2017 | OTHER | Dimension Therapeutics, Inc. | 32,069 | — | deriv |
| 07 Nov 2017 | OTHER | Dimension Therapeutics, Inc. | 17,000 | — | deriv |
| 25 May 2017 | GRANT_AWARD | Dimension Therapeutics, Inc. | 17,000 | 0.00 USD | deriv |
| 19 May 2016 | GRANT_AWARD | Dimension Therapeutics, Inc. | 32,069 | 0.00 USD | deriv |
| 27 Oct 2015 | PURCHASE | Dimension Therapeutics, Inc. | 961,538 | 13.00 USD | |
| 27 Oct 2015 | CONVERSION | Dimension Therapeutics, Inc. | 1,097,745 | — | |
| 27 Oct 2015 | CONVERSION | Dimension Therapeutics, Inc. | 3,208,711 | — | deriv |
| 20 Mar 2014 | GRANT_AWARD | Versartis, Inc. | 35,000 | 0.00 USD | deriv |